
Currently out of the existing stock ratings of Joel Beatty, 72 are a HOLD (16.29%), 7 are a SELL (1.58%), 363 are a BUY (82.13%).
Analyst Joel Beatty, currently employed at BAIRD, has had 59.95% of price targets met with an average potential upside of 46.74%, reached in 359 days on average.
Joel Beatty has documented 867 price targets and ratings displayed on 80 stocks. The coverage is on Healthcare, Consumer Defensive, Energy, Industrials sectors.
Most recent stock forecast was given on PRAX, Praxis Precision Medicines.
Analyst best performing recommendations are on NK (NANTKWEST).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA) on 3/3/2023. The price target of $11 was fulfilled within 3 days with a profit of $4.57 (71.07%), with a performance score of 236.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jul-2025
$225
$59.96 (36.33%)
$315
15 days ago
(02-Nov-2026)
4/10 (40%)
$60 (36.36%)
11
Buy Since 17-Dec-2018
$323
$157.96 (95.71%)
$429
15 days ago
(02-Nov-2026)
14/17 (82.35%)
$158 (95.76%)
319
Buy Since 28-Jun-2024
$380
$214.96 (130.25%)
$450
15 days ago
(02-Nov-2026)
1/6 (16.67%)
$215 (130.30%)
110
Buy Since 30-Oct-2026
$315
$149.96 (90.86%)
$333
18 days ago
(30-Oct-2026)
6/7 (85.71%)
$150 (90.91%)
153
Buy Since 20-Sep-2022
$280
$114.96 (69.66%)
$345
18 days ago
(30-Oct-2026)
31/39 (79.49%)
$115 (69.70%)
180
Which stock is Joel Beatty most bullish on?
Which stock is Joel Beatty most reserved on?
What Year was the first public recommendation made by Joel Beatty?